The perspective of obese and postbariatric patients on drug-induced weight gain - a cross-sectional survey focusing on adherence and drug safety

Recruiting

Conditions: Bariatric surgery
E66
Obesity

Registration Number: DRKS00027962

Lead Sponsor: niversität Leipzig

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 220

Inclusion Criteria

Obesity (BMI >= 30 kg/m2) or history of bariatric surgery
- Intake of at least one drug as long-term medication at the time of data collection
- Written consent to participate in the study
- Sufficient knowledge of the german language to participate in the survey

Exclusion Criteria

- Rejection of participation by the patient
- Rejection of participation by the treating physician of the study centre
- No fulfillment of the inclusion criteria

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Number of patients who altered their medication intake due to experiencing weight gain (retrospective)<br>- Number of patients who do not follow their current agreed drug regimen due to expierences or concerns regarding weight gain

Secondary Outcome Measures

Name	Time	Method
- Type and number of drugs or drug classes that led to weight gain (patient reported)<br>- Type and number of drugs in the patient's long term medication from which the patients fear weight gain or hampered weight loss<br>- Patient reported burden caused by experiencing or fearing drug-induced weight gain<br>- Type of actions taken by the patient and/or the physician against drug-induced weight gain<br>- Type and number of drugs or drug classes in the patient's long-term medication that patients associate with potential weight gain<br>- Type and number of drugs in the patients' medication list which are characterized as obesogenic drugs according to scientific literature<br>- Patient reported tolerability of (hypothetic) drug-induced weight gain